egtazic acid has been researched along with Multiple Myeloma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erez, O; Friedman, J; Goldstaub, D; Kahana, C | 1 |
| Avcu, F; Nevruz, O; Pekel, A; Sengul, A; Ural, AU; Yalcin, A; Yilmaz, MI; Zerman, M | 1 |
| Azuma, T; Froelich, CJ; Fujita, S; Kuzushima, K; Otsuki, T; Yasukawa, M | 1 |
| Herrera, GA; Sanders, PW; White, CR; Zhu, L | 1 |
4 other study(ies) available for egtazic acid and Multiple Myeloma
| Article | Year |
|---|---|
Putrescine activates oxidative stress dependent apoptotic death in ornithine decarboxylase overproducing mouse myeloma cells.
Topics: Animals; Apoptosis; Blotting, Western; Calcium; Caspase 2; Caspases; Chelating Agents; Cytochrome c Group; Egtazic Acid; Enzyme Inhibitors; Guanidines; Humans; Mice; Mitochondria; Multiple Myeloma; Nitric Oxide Synthase; Ornithine Decarboxylase; Oxidative Stress; Poly(ADP-ribose) Polymerases; Polyamines; Putrescine; tert-Butylhydroperoxide; Time Factors; Tumor Cells, Cultured; Up-Regulation | 2002 |
The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Cycle; Cell Division; Dexamethasone; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Egtazic Acid; Enzyme Inhibitors; Humans; Imidazoles; Leukemia, Plasma Cell; Multiple Myeloma; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protein Kinase C; Staurosporine; Thalidomide; Tumor Cells, Cultured; Zoledronic Acid | 2003 |
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
Topics: Antigens, Neoplasm; Bone Marrow Cells; Calcium; Cell Line; Cell Line, Tumor; Chromium; Cytoplasmic Granules; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Exocytosis; Flow Cytometry; Genes, MHC Class I; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Macrolides; Membrane Glycoproteins; Multiple Myeloma; Peptides; Perforin; Pore Forming Cytotoxic Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Cytotoxic; Treatment Outcome; WT1 Proteins | 2004 |
Immunoglobulin light chain alters mesangial cell calcium homeostasis.
Topics: Adenosine Triphosphate; Animals; Aorta; Calcium; Cells, Cultured; Egtazic Acid; Glomerular Mesangium; Homeostasis; Humans; Immunoglobulin kappa-Chains; Inositol; Kidney Cortex; Kinetics; Male; Multiple Myeloma; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Thapsigargin; Time Factors | 1997 |